ABSTRACT
The genes involved in signal transduction are major candidates in association studies on affective disorders and responses to antidepressants. We investigated whether the C825T polymorphism of the β3 subunit of G protein (GNB3) gene is associated with the symptom severity or treatment response of major depressive disorders (MDDs) in a Korean sample of 106 MDD patients; our study also included 133 healthy controls. Hypertensive subjects were excluded from the study because association between GNB3 variants and hypertension has been reported in previous studies. We found significantly more carriers of the 825T allele in MDD patients than in normal controls (χ2=6.37, P=0.012; OR=2.19, 95% CI 1.18–4.05). The T-allele carriers showed higher scores than those with the CC genotype in the baseline total and in some subcategories of the Hamilton Depression Rating Scale (P<0.05). We also found a statistically significant association between T-allele carriers and antidepressant treatment response (P<0.05). These results suggest that the T allele of the C825T polymorphism in the GNB3 gene is associated with MDD. It was also demonstrated that MDD patients bearing the T allele had a severe symptomatology and a better response to antidepressant treatment than patients without the T allele.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CGI-S:
-
clinical global impression of severity
- DNA:
-
deoxyribonucleic acid
- GNB3:
-
β3 subunit of G protein
- HAM-D:
-
Hamilton Depression Rating Scale
- MDD:
-
major depressive disorder
- SNP:
-
single-nucleotide polymorphism
References
Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, Shekter LR et al. Molecular basis for interactions of G protein betagamma subunits with effectors. Science 1998; 280: 1271–1274.
Hamm HE . The many faces of G protein signaling. J Biol Chem 1998; 273: 669–672.
Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18: 45–48.
Siffert W . G-protein beta3 subunit 825T allele and hypertension. Curr Hypertens Rep 2003; 5: 47–53.
Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ . G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 1998; 32: 1094–1097.
Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP . Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension 1999; 34: 1193–1196.
Hengstenberg C, Schunkert H, Mayer B, Doring A, Lowel H, Hense HW et al. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001; 49: 820–827.
Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C et al. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999; 10: 1921–1930.
Hegele RA, Anderson C, Young TK, Connelly PW . G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 1999; 9: 972–977.
Zill P, Baghai TC, Zwanzger P, Schule C, Minov C, Riedel M et al. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport 2000; 11: 1893–1897.
Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D et al. SSRIs antidepressant activity is influenced by Gbeta3 variants. Eur Neuropsychopharmacol 2003; 13: 117–122.
Bondy B, Baghai TC, Zill P, Bottlender R, Jaeger M, Minov C et al. Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry 2002; 7: 1120–1126.
Kunugi H, Kato T, Fukuda R, Tatsumi M, Sakai T, Nanko S . Association study of C825T polymorphism of the G-protein beta3 subunit gene with schizophrenia and mood disorders. J Neural Transm 2002; 109: 213–218.
Lin CN, Tsai SJ, Hong CJ . Association analysis of a functional G protein beta3 subunit gene polymorphism (C825T) in mood disorders. Neuropsychobiology 2001; 44: 118–121.
Chang HW, Yen CY, Liu SY, Singer G, Shih IeM . Genotype analysis using human hair shaft. Cancer Epidemiol Biomarkers Prev 2002; 11: 925–929.
Virchow S, Ansorge N, Rosskopf D, Rubben H, Siffert W . The G protein beta3 subunit splice variant Gbeta3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8. Naunyn-Schmiedeberg's Arch Pharmacol 1999; 360: 27–32.
Rosskopf D, Manthey I, Habich C, Kielbik M, Eisenhardt A, Nikula C et al. Identification and characterization of Gbeta3s2, a novel splice variant of the G-protein beta3 subunit. Biochem J 2003; 371: 223–232.
Rosskopf D, Koch K, Habich C, Geerdes J, Ludwig A, Wilhelms S et al. Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins. Cell Signal 2003; 15: 479–488.
Han OS, Hong JP Structured Clinical Interview for DSM-IV Axis I Disorder—Korean Version. Hana Medical Publishing Co: Seoul, Korea 2000.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC 1994.
Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–296.
Guy W ECDEU Assessment Manual for Psychopharmacology, Revised, US Department of Health, Education, and Welfare ADM 76-338. Superintendent of Documents. US Government Printing Office: Washington, DC 1976.
Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y . G protein beta3 subunit variant and essential hypertension in Japanese. Hypertension 1998; 32: 935–938.
Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D et al. The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension. Hypertension 1999; 33: 1175–1178.
Larson N, Hutchinson R, Boerwinkle E . Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000; 35: 1297–1300.
Serretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E . Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry 1999; 4: 280–283.
Rothman KJ . No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43–46.
Acknowledgements
This work was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (KPGRN-R-04).
Author information
Authors and Affiliations
Corresponding author
Additional information
Duality of Interest
None declared.
Rights and permissions
About this article
Cite this article
Lee, HJ., Cha, JH., Ham, BJ. et al. Association between a G-protein β3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J 4, 29–33 (2004). https://doi.org/10.1038/sj.tpj.6500217
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500217
Keywords
This article is cited by
-
Molecular and genetic basis of depression
Journal of Genetics (2014)
-
Poor replication of candidate genes for major depressive disorder using genome-wide association data
Molecular Psychiatry (2011)
-
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Molecular Psychiatry (2010)
-
Meta-analyses of genetic studies on major depressive disorder
Molecular Psychiatry (2008)
-
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach
BMC Psychiatry (2007)